Literature DB >> 29521247

Evaluating the Effect of Oral N-acetylcysteine as an Adjuvant Treatment on Clinical Outcomes of Patients with Rheumatoid Arthritis: A Randomized, Double Blind Clinical Trial.

Minoo Batooei1, Ahmad Tahamoli-Roudsari2, Zahra Basiri2, Fatemeh Yasrebifar1, Maryam Shahdoust3, Azadeh Eshraghi4, Maryam Mehrpooya1, Sara Ataei1.   

Abstract

OBJECTIVE: Oxidative stress and Overproduction of pro-inflammatory cytokines are contributed in Rheumatoid Arthritis (RA) pathogenesis. N-acetylcysteine (NAC) is an antioxidant and antiinflammatory agent which demonstrated analgesic effects in some studies. This study is designed to assess the effects of oral NAC as an adjuvant therapy on the clinical outcomes of patients with active RA.
METHODS: In this randomized clinical trial, 51 RA patients with active RA were studied in 2 groups: NAC group (27 patients) received standard treatment of RA and 600 mg NAC twice a day for 12 weeks, and placebo group (24 patients) received the standard treatment of RA and placebo. Disease activity score (DAS28) was used to assess the activity of RA, Visual Analog Scale (VAS) for the severity of pain, Health Assessment Questionnaire (HAQ) for the patients' physical performance, and Global Health (GH) parameter for the patients' assessment of their disease activity. The number of tender and swollen joints and Erythrocyte Sedimentation Rate (ESR) were also determined for each patient. Data were analyzed using SPSS version 16.0 (Chicago, IL, USA).
RESULTS: After 12 weeks of intervention, there were no significant differences between two groups in DAS28 score and ESR (P values were 0.4 and 0.6, respectively). However, GH, VAS, and HAQ scores were improved significantly in the NAC group compared to the placebo group.
CONCLUSION: Our findings indicate that oral administration of NAC may be associated with improving health status in RA patients and considered as an adjuvant therapy in these patients. Further studies with larger sample size, longer study duration and higher doses of NAC are needed to confirm the effects of oral NAC in RA patients. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Clinical outcomes; DAS28; N-acetylcysteine; Visual Analog Scale (VAS); oxidative stress; rheumatoid arteritis.

Mesh:

Substances:

Year:  2018        PMID: 29521247     DOI: 10.2174/1574887113666180307151937

Source DB:  PubMed          Journal:  Rev Recent Clin Trials        ISSN: 1574-8871


  15 in total

1.  Oxidative hotspots on actin promote skeletal muscle weakness in rheumatoid arthritis.

Authors:  Maarten M Steinz; Malin Persson; Bejan Aresh; Karl Olsson; Arthur J Cheng; Emma Ahlstrand; Mats Lilja; Tommy R Lundberg; Eric Rullman; Kristina Ängeby Möller; Katalin Sandor; Sofia Ajeganova; Takashi Yamada; Nicole Beard; Björn Cg Karlsson; Pasi Tavi; Ellinor Kenne; Camilla I Svensson; Dilson E Rassier; Roger Karlsson; Ran Friedman; Thomas Gustafsson; Johanna T Lanner
Journal:  JCI Insight       Date:  2019-03-28

2.  Effects of N-acetylcysteine supplementation on disease activity, oxidative stress, and inflammatory and metabolic parameters in rheumatoid arthritis patients: a randomized double-blind placebo-controlled trial.

Authors:  Kamal Esalatmanesh; Alireza Jamali; Roozbeh Esalatmanesh; Zahra Soleimani; Alireza Khabbazi; Aida Malek Mahdavi
Journal:  Amino Acids       Date:  2022-02-08       Impact factor: 3.520

3.  Inflammatory and Oxidative Stress Markers-Mirror Tools in Rheumatoid Arthritis.

Authors:  Radu Răzvan Mititelu; Rodica Pădureanu; Manuela Băcănoiu; Vlad Pădureanu; Anca Oana Docea; Daniela Calina; Andreea Lili Barbulescu; Ana Maria Buga
Journal:  Biomedicines       Date:  2020-05-15

4.  Resveratrol alleviates inflammatory injury and enhances the apoptosis of fibroblast‑like synoviocytes via mitochondrial dysfunction and ER stress in rats with adjuvant arthritis.

Authors:  Jinsen Lu; Yongshun Zheng; Jiazhao Yang; Junqiang Zhang; Wei Cao; Xiaoyu Chen; Shiyuan Fang
Journal:  Mol Med Rep       Date:  2019-05-22       Impact factor: 2.952

5.  Ameliorative Effects Of N-Acetylcysteine As Adjunct Therapy On Symptoms Of Painful Diabetic Neuropathy.

Authors:  Narges Heidari; Firozeh Sajedi; Younes Mohammadi; Mahtabalsadat Mirjalili; Maryam Mehrpooya
Journal:  J Pain Res       Date:  2019-11-19       Impact factor: 3.133

6.  Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritis.

Authors:  Marta F Bustamante; Meritxall Agustín-Perez; Francesca Cedola; Roxana Coras; Rekha Narasimhan; Shahrokh Golshan; Monica Guma
Journal:  Contemp Clin Trials Commun       Date:  2020-01-21

Review 7.  Oxidative Stress in Rheumatoid Arthritis: What the Future Might Hold regarding Novel Biomarkers and Add-On Therapies.

Authors:  Lucas José Sá da Fonseca; Valéria Nunes-Souza; Marília Oliveira Fonseca Goulart; Luiza Antas Rabelo
Journal:  Oxid Med Cell Longev       Date:  2019-12-14       Impact factor: 6.543

8.  Clinical Validation of a Multi-Biomarker Assay for the Evaluation of Chronic Pain Patients in a Cross-Sectional, Observational Study.

Authors:  Kasra Amirdelfan; Jason E Pope; Joshua Gunn; Melissa M Hill; Bradley M Cotten; John E Beresh; Douglas Dobecki; Nathan Miller; Pankaj Mehta; George Girardi; Timothy R Deer
Journal:  Pain Ther       Date:  2020-06-03

Review 9.  Reactive Oxygen Species in Autoimmune Cells: Function, Differentiation, and Metabolism.

Authors:  Weiji Lin; Pan Shen; Yaqin Song; Ying Huang; Shenghao Tu
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 10.  Skeletal muscle redox signaling in rheumatoid arthritis.

Authors:  Maarten M Steinz; Estela Santos-Alves; Johanna T Lanner
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.